U-turn on drugs for Alzheimer's cases
a U-turn by the health watchdog means hundreds of thousands of patients refused access to Alzheimer's drugs may now get them.
New draft health guidance says the medicines should now be made available to people who have mild disease.
Full story: Page 5.